Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
To assess the effectiveness of aripiprazole once-monthly in the maintenance treatment of
patients with a diagnosis of schizophrenia as defined by the Diagnostic and Statistical
Manual of Mental Disorders, 4th edition, Text Revision (DSM-IV-TR®), in a naturalistic care
setting by comparing it to an existing long-acting antipsychotic, paliperidone palmitate.